Idexx Laboratories
IDXX
1,148 hedge funds and large institutions have $39.1B invested in Idexx Laboratories in 2024 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 404 increasing their positions, 414 reducing their positions, and 86 closing their positions.
13% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 86
0% less funds holding
Funds holding: 1,153 → 1,148 (-5)
2% less repeat investments, than reductions
Existing positions increased: 404 | Existing positions reduced: 414
5% less capital invested
Capital invested by funds: $41.1B → $39.1B (-$1.99B)
1.86% less ownership
Funds ownership: 89.26% → 87.39% (-1.9%)
24% less funds holding in top 10
Funds holding in top 10: 29 → 22 (-7)
53% less call options, than puts
Call options by funds: $104M | Put options by funds: $223M
Top Buyers
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$132M |
| 2 |
BlackRock
New York
|
+$83.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$78.7M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$78.4M |
| 5 |
Man Group
London,
United Kingdom
|
+$65.9M |
Top Sellers
| 1 |
Capital World Investors
Los Angeles,
California
|
-$568M |
| 2 |
Morgan Stanley
New York
|
-$527M |
| 3 |
Select Equity Group
New York
|
-$160M |
| 4 |
UB
UMB Bank
Kansas City,
Missouri
|
-$122M |
| 5 |
BAMCO Inc
New York
|
-$107M |
IDXX Hedge Fund Activity: Q1 2024 in Review
1,148 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2024, worth a combined $39.1B — down 4.8% from $41.1B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new IDXX positions and 86 closed out — a net gain of 11 holders — while 404 added to existing stakes and 414 trimmed.
The largest buyer was Qube Research & Technologies (QRT), adding an estimated $132M. The largest seller was Capital World Investors, exiting entirely with an estimated $568M sold.
- 1,148 institutional investors held Idexx Laboratories (IDXX) as of Q1 2024, down from 1,153 in Q4 2023.
- Funds reported $39.1B of Idexx Laboratories stock for Q1 2024, down 4.8% quarter-over-quarter.
- 97 funds opened new Idexx Laboratories positions in Q1 2024 and 86 closed out, a net change of +11 holders.
- The largest Idexx Laboratories buyer in Q1 2024 was Qube Research & Technologies (QRT), an estimated $132M added.
- The largest Idexx Laboratories seller in Q1 2024 was Capital World Investors, an estimated $568M sold.
Based on aggregated 13F filings for Q1 2024.